The European Journal of Medicine and Translational BioSciences (EJMTB) is an international, peer-reviewed, Diamond Open Access scientific journal published by Western Balkans University (WBU).
The journal is designed to support scientific excellence, interdisciplinary collaboration, research integrity, and the international visibility of scholarly work in medicine, translational science, public health, healthcare innovation, and related biomedical disciplines.
Mission
The journal provides a high-quality, peer-reviewed academic platform for research, policy analysis, and scholarly debate in health systems, biomedical sciences, translational science, pharmaceutical policy, public health, and healthcare innovation. It promotes scientific integrity, international collaboration, open science, interdisciplinary research, and evidence-informed decision-making.
Aims & Objectives
- Promote high-quality scientific research in medicine, pharmacy, public health, translational science, and healthcare innovation.
- Strengthen the visibility of scientific research from Albania, the Western Balkans, and international academic partners.
- Support evidence-informed healthcare policy and practice.
- Encourage interdisciplinary collaboration between academia, healthcare institutions, industry, and policymakers.
- Develop a credible publishing platform aligned with COPE, ICMJE, DOAJ, Scopus, and Web of Science standards.
Scope
The journal welcomes original research, reviews, policy papers, short communications, editorials, commentaries, and case studies across health systems and policy; public health and epidemiology; pharmaceutical policy; translational and clinical sciences; primary and integrated care; nursing, physiotherapy, dentistry and allied health; digital health and AI in healthcare; medical technology; health economics; patient safety; preventive medicine; global and SDG-related health; and medical education.
Open Access
EJMTB fully supports Diamond Open Access publishing. All articles are made freely and permanently accessible online immediately upon publication, with no submission or publication fees charged to authors and no subscription fees charged to readers.